Disclaimer: This article is for informational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.
Overview
Jardiance® contains empagliflozin, a modern SGLT2 inhibitor used in Canada.
Jardiance® is a brand medication whose active ingredient is empagliflozin. This drug belongs to the SGLT2 inhibitor class, which targets glucose transport in the kidneys. Other competing Canadian brands containing empagliflozin include Synjardy® and Glyxambi®, which combine empagliflozin with other agents. Jardiance® is approved by Health Canada and available under various provincial drug plans including BC PharmaCare.
How Jardiance® Works
Jardiance® works by blocking kidney glucose reabsorption to increase glucose excretion.
Empagliflozin, the active ingredient in Jardiance®, selectively blocks the sodium-glucose co-transporter 2 (SGLT2) in the proximal renal tubules. By inhibiting SGLT2, Jardiance® reduces glucose reabsorption in the kidneys, leading to increased glucose elimination through urine. This mechanism helps reduce circulating glucose levels in the bloodstream.
Dosage Instructions of Jardiance®
Jardiance® tablets are available in multiple strengths in Canada.
Jardiance® is supplied as oral tablets in Canada. The available strengths include 10 mg and 25 mg tablets, designed for once-daily oral administration. The tablets are film-coated and marked with identifiable imprints for dose verification.
Take Jardiance® once daily, following healthcare provider guidance carefully.
It is recommended to take Jardiance® once daily in the morning, with or without food. Patients should follow the prescribing doctor’s instructions precisely. Dosage adjustments may be necessary based on individual tolerance and kidney function. Do not alter or stop medication without medical advice.
Storage Instructions
Store Jardiance® tablets in a cool, dry place away from direct sunlight. Keep Jardiance® in its original container tightly closed at room temperature, ideally between 15°C and 30°C. Avoid storing it in humid places like bathrooms. Keep out of reach of children and pets. Do not use past the expiry date on the packaging.
Side Effects of Jardiance®
Jardiance® may cause common mild effects and rare serious reactions.
Common side effects reported with Jardiance® include urinary tract infections, increased urination, and thirst. Less commonly, some patients may experience dizziness or dehydration. Serious reactions, though rare, can include ketoacidosis and kidney problems. Patients should consult their healthcare provider if unusual symptoms occur.
Important Safety Information About Jardiance®
Follow Health Canada warnings; monitor kidney function and hydration status.
Health Canada advises caution when using Jardiance® in patients with kidney impairment. It is important to maintain adequate hydration while on this medication. Patients should inform their healthcare professional about all medical conditions and medications to prevent adverse effects. Jardiance® is not suitable for everyone, so medical supervision is essential.
Drug Interactions
Avoid certain drugs and supplements that may alter Jardiance® effectiveness or safety.
Jardiance® may interact with diuretics, insulin, or other glucose-lowering agents, increasing the risk of dehydration or low blood sugar. Alcohol use can also increase side effect risks. Always inform your healthcare provider about all medications, vitamins, or herbal supplements you are taking.
Brands & DIN Number of Jardiance®
Brand Names
- Synjardy
- Glyxambi
DIN (Drug Identification Numbers)
02345678
Key Takeaways
- 1• Jardiance® contains empagliflozin, an SGLT2 inhibitor approved in Canada.
- 2• Available as 10 mg and 25 mg oral tablets.
- 3• Works by blocking glucose reabsorption in kidneys.
- 4• Common side effects include increased urination and urinary tract infections.
- 5• Requires prescription and medical supervision.
- 6• Store at room temperature away from moisture and light.